Streetbeat News

Revenues

SCVL

Shoe Carnival has announced its preliminary earnings per share (EPS) for fiscal year 2023 to be between $2.65 and $2.75, with revenue expected to be around $1.176 billion.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 9:47 pm

DENN

Denny's forecasts its 2024 adjusted EBITDA to be in the range of $85M-$89M, with domestic system-wide same-restaurant sales expected to be between 0% and 3%.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 9:43 pm

REZI

Resideo Technologies (REZI) provided its Q1 and full year 2024 financial outlook, forecasting Q1 EPS of $0.28-$0.38 and revenue of $1.46B-$1.51B, both below estimates. The full year 2024 EPS is expected to be $1.48-$1.88 with revenue projections of $6.08B-$6.28B, also below estimates. The company anticipates at least $320 million in cash from operating activities for the full year.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 9:36 pm

Z

ZG

Zillow Group projects its Q1 revenue to be between $495M and $510M, which is around the analyst estimate of $500.67M.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 9:30 pm

LOPE

Grand Canyon Education provided its FY24 earnings forecast, expecting adjusted EPS to range between $7.39 and $7.91, compared to the estimated $7.87. The company also anticipates revenue to be between $1.016 billion and $1.040 billion, versus the estimated $1.023 billion.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 9:30 pm

QDEL

QuidelOrtho projects FY24 total revenues to be between $2.76B-$3.07B, slightly below the estimated $2.948B. The company also forecasts adjusted EPS to range from $2.40-$3.07, significantly lower than the estimated $5.07.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 9:28 pm

BFAM

Bright Horizons Family Solutions provided its FY24 adjusted EPS guidance in the range of $3.00-$3.20, compared to the consensus estimate of $3.13. The company also expects revenue to be between $2.6 billion and $2.7 billion, aligning with the lower end of the consensus estimate of $2.60 billion.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 9:27 pm

KRG

Kite Realty Group Trust (KRG) projects its FY24 EPS to be between $0.29 and $0.35 and NAREIT FFO to range from $2.00 to $2.06 per diluted share. These forecasts are based on assumptions including a Same Property NOI growth of 1.0% to 2.0% and a bad debt assumption of 0.75% to 1.25% of total revenues.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 9:25 pm

AKR

Acadia Realty Trust (AKR) reported a Q4 FFO of $0.28 per share, up 3.7% from $0.27 YoY. Quarterly sales were $84.20M, beating the $75.11M estimate, a 6.14% increase from $79.33M YoY.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 9:24 pm

MACK

Merrimack Pharmaceuticals announced that Ipsen's FDA approval of the supplemental New Drug Application (sNDA) for Onivyde has triggered a $225 million payment from Ipsen to Merrimack. This milestone payment is part of the terms agreed upon in the licensing deal between the two companies.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 9:24 pm